Information Provided By:
Fly News Breaks for December 8, 2016
EVHC
Dec 8, 2016 | 06:55 EDT
JPMorgan analyst Gary Taylor reinstated Envision Healthcare with an Overweight rating and $89 price target. The analyst believes the Amsurg acquisition makes strategic sense.
News For EVHC From the Last 2 Days
There are no results for your query EVHC